Genetisk Studie av Amyotrofisk Lateral Sklerose (ALS)

Status: Recruiting
Location: See all (17) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 100
Healthy Volunteers: f
View:

• Probable or definite ALS

• Eligible to consent

Locations
Other Locations
Norway
Haukeland University Hospital, Department of Neurology
RECRUITING
Bergen
Nordland Hospital Trust, Department of Neurology
RECRUITING
Bodø
Vestre Viken Hospital Trust, Department of Neurology
RECRUITING
Drammen
Førde Hospital Trust, Department of Neurology
RECRUITING
Førde
Østfold Hospital Trust, Department of Neurology
RECRUITING
Grålum
Fonna Hospital Trust, Department of Neurology
RECRUITING
Haugesund
Sørlandet Hospital Trust, Department of Neurology
RECRUITING
Kristiansand
Innlandet Hospital Trust, Department of Neurology
RECRUITING
Lillehammer
Akershus University Hospital, Department of Neurology
RECRUITING
Lørenskog
Møre and Romsdal Hospital Trust, Department of Neurology
RECRUITING
Molde
Nord-Trøndelag Hospital Trust, Department of Neurology
RECRUITING
Namsos
Oslo University Hospital, Department of Neurology
RECRUITING
Oslo
Telemark Hospital, Department of Neurology
RECRUITING
Skien
Stavanger University Hospital, Department of Neurology
RECRUITING
Stavanger
Vestfold Hospital Trust, Department of Neurology
RECRUITING
Tønsberg
University hospital of North Norway, Department of Neurology
RECRUITING
Tromsø
St. Olavs Hospital, Department of Neurology
RECRUITING
Trondheim
Contact Information
Primary
Helle Høyer
helle.hoyer@sthf.no
35003146
Time Frame
Start Date: 2019-08-01
Estimated Completion Date: 2035-12-31
Participants
Target number of participants: 1200
Treatments
Individuals diagnosed with ALS
Individuals diagnosed with ALS that are being followed through the Norwegian health-care system. ALS patients ( probable or definite per El-Escorial criteria)
Sponsors
Collaborators: Helse Sor-Ost, ALS Norge
Leads: Sykehuset Telemark

This content was sourced from clinicaltrials.gov